Chimiothérapie Chimiothérapie Kadcyla Kadcyla Chimiothérapie Kadcyla Unknown Jumat, 10 November 2017 Pertuzumab plus trastuzumab plus docetaxel for metastatic. Outcomes. The median progressionfree survival become 12.Four months inside the ma...
